Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (421-430 of 651) with videos related to

Pageof 66
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 3, 2026
Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific PhenotypesSarah Diana Gorbatov, Marisa A Bittoni, Anna H Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group studyS G Taylor, L A Kalish, J E Olson, et al.
Human Gene Therapy|December 31, 1997
Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cellsD C Tang, R S Jennelle, Z Shi, et al.
Clinical Lung Cancer|January 8, 2021
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele FrequencyJean G Bustamante Alvarez, Sarah Janse, Dwight H Owen, et al.
Clinical Lung Cancer|March 19, 2020
Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical ConsiderationsJae Baek, Dwight H Owen, Robert E Merritt, et al.
Cancer Cell|October 19, 2004
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisLi Yang, Laura M DeBusk, Koari Fukuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597Vicki Keedy, Wei Wang, Joan Schiller, et al.
The Journal of Clinical Investigation|February 27, 2014
Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinomaMarcin Imielinski, Heidi Greulich, Bethany Kaplan, et al.
Nature Immunology|March 23, 2001
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathwayM Terabe, S Matsui, N Noben-Trauth, et al.
Cancer|November 1, 1983
Cooperative groups and community hospitals. Measurement of impact in the community hospitalsC B Begg, M Zelen, P P Carbone, et al.
Pageof 66

Showing results (421-430 of 651) with videos related to

Sort By:
Pageof 66
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 3, 2026
Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific PhenotypesSarah Diana Gorbatov, Marisa A Bittoni, Anna H Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group studyS G Taylor, L A Kalish, J E Olson, et al.
Human Gene Therapy|December 31, 1997
Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cellsD C Tang, R S Jennelle, Z Shi, et al.
Clinical Lung Cancer|January 8, 2021
Treatment of Non-Small-Cell Lung Cancer Based on Circulating Cell-Free DNA and Impact of Variation Allele FrequencyJean G Bustamante Alvarez, Sarah Janse, Dwight H Owen, et al.
Clinical Lung Cancer|March 19, 2020
Minimally Invasive Lobectomy for Residual Primary Tumors of Advanced Non-Small-Cell Lung Cancer After Treatment With Immune Checkpoint Inhibitors: Case Series and Clinical ConsiderationsJae Baek, Dwight H Owen, Robert E Merritt, et al.
Cancer Cell|October 19, 2004
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesisLi Yang, Laura M DeBusk, Koari Fukuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597Vicki Keedy, Wei Wang, Joan Schiller, et al.
The Journal of Clinical Investigation|February 27, 2014
Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinomaMarcin Imielinski, Heidi Greulich, Bethany Kaplan, et al.
Nature Immunology|March 23, 2001
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathwayM Terabe, S Matsui, N Noben-Trauth, et al.
Cancer|November 1, 1983
Cooperative groups and community hospitals. Measurement of impact in the community hospitalsC B Begg, M Zelen, P P Carbone, et al.
Pageof 66